Physician profile
Albert Warren
NPI 1871770412
$1,182.24
in general payments reported to CMS, 2019-2025
22 companies · $33.63 in 2025
The $33.63 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $588 · 2020: $86.27 · 2021: $355 · 2022: $105 · 2023: $14.31 · 2025: $33.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $189.91 | 2019 | |
| Novo Nordisk INC | $174.39 | 2019-2021 | |
| Astellas Pharma US INC | $132.97 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $123.68 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $86.28 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $81.00 | 2019-2021 | |
| Zealand Pharma US, INC. | $63.34 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.80 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $35.93 | 2019-2021 | |
| Abbvie INC. | $33.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $27.06 | 2019-2020 | |
| Amarin Pharma, INC. | $24.56 | 2021 | |
| Dexcom, INC. | $24.30 | 2021 | |
| Sanofi-Aventis U.S. LLC | $21.21 | 2021 | |
| Medtronic, INC. | $17.73 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $17.46 | 2022 | |
| Sunovion Pharmaceuticals INC. | $17.10 | 2021 | |
| Lilly USA, LLC | $12.63 | 2021 | |
| Amgen INC. | $12.35 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.18 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.38 | 2021 | |
| Biogen, INC. | $11.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Warren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.